Analysts Raise Price Targets for UnitedHealth After Strong Q3 Performance
UnitedHealth Group (UNH) surpassed third-quarter expectations, demonstrating resilience amid elevated medical costs. RBC Capital and Leerink Partners responded by lifting price targets, signaling confidence in the insurer's margin expansion strategy.
RBC's Ben Hendrix boosted his target to $408, citing management's pricing discipline and planned market exits. Leerink's Whit Mayo followed suit, raising to $410 while praising execution against revised benchmarks. Both analysts maintained Buy ratings, projecting earnings growth within the company's long-term 13%-16% target range.